Total Clarity Wealth Management, Inc. Adaptimmune Therapeutics PLC Transaction History

Total Clarity Wealth Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$1.73 - $4.06 $346 - $811	-200 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$3.5 - $5.68 $3,500 - $5,680	-1,000 Reduced 83.33%	200 $1,000
Q3 2021 Oct 21, 2021	BUY	$3.44 - $6.37 $4,128 - $7,644	1,200 New	1,200 $6,000
Q2 2021 Jul 26, 2021	SELL	$3.86 - $5.78 $4,632 - $6,936	-1,200 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$4.9 - $6.83 $5,880 - $8,196	1,200 New	1,200 $6,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $114M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.